The breast cancer risk assessment test that detected Olivia Munn's aggressive Luminal B cancer has now identified breast ...

Mary Beckerle is stepping down from her long tenure as CEO of Huntsman Cancer Institute at the University of Utah. Beckerle ...

Teclistamab-cqyv is a T-cell-engaging bispecific antibody that targets multiple myeloma cells via the B-cell maturation ...

Researchers discovered how to flip the structure of complex drug compounds using a simple reagent, offering a game-changing ...

Revolution Medicines' proprietary data will train a bespoke version of NeuralPLexer, an AI model for protein-ligand ...

A new drug targets RAS-PI3Kα pathways without harmful side effects. It was developed using high-performance computing and AI.

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center may help explain why certain liver ...

The hunt for a medical breakthrough has been caught up in the Trump administration's political assault on the university.

A fundamental discovery by University of Missouri scientists could help solve one of the most frustrating challenges in ...

Recent research on MCL-1, a critical protein that is an attractive target for cancer drug development, helps explain why some ...

We also found that tumors release a protein called Activin-A, which acts on blood vessels to cause the leakiness and, ultimately, loss of blood vessels in the muscle. When we used a gene therapy to ...

Cancer is nonpartisan. It touches everyone — cutting across religion, race, ethnicity, sexual orientation and socioeconomic ...